Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0000950170-23-071883

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kottayil George Director 2023-12-19 Grant or award · Stock Options (Right to Buy) +22,500 22,500 D
Loading xslF345X05/ownership.xml…